EPA Incorporation and Immune responses after nutritional supplementation in Cancer patients.
Completed
- Conditions
- Cancer patients
- Registration Number
- NL-OMON25291
- Lead Sponsor
- Danone Research ¨C Centre for Specialised Nutrition
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1. Pathologically confirmed solid tumor(s);
2. Body Mass Index 18.5 - 30 kg/ m2;
Exclusion Criteria
1. Surgery, radiotherapy, chemotherapy and or hormone therapy less than 2 months ago or planned within the study period;
2. Use of supplements containing fish oil, vitamins or oil supplements (e.g. evening primrose oil) during the previous 4 weeks;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Incorporation kinetics of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in membrane phospholipids of white and red blood cells and plasma phospholipids;<br /><br>2. Effects on ex vivo immune responses in cancer patients.
- Secondary Outcome Measures
Name Time Method Effects of nutritional supplementation on inflammatory status.